2021
DOI: 10.1016/j.biopha.2021.111495
|View full text |Cite
|
Sign up to set email alerts
|

Antiproliferative activity of thiazole and oxazole derivatives: A systematic review of in vitro and in vivo studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
25
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(28 citation statements)
references
References 42 publications
1
25
0
Order By: Relevance
“…There is a vast number of thiazoles that exhibit a wide range of pharmacological activities, including antibacterial [ 29 ], anticancer [ 30 ], antifungal [ 31 ], anti-inflammatory [ 32 ], antioxidant [ 33 ] and anti-tubercular activities [ 34 ]. Therefore, we believe that the merging of pyrazole and thiazole moieties will result in a class of pharmacophores that exhibit promising biological activities; in fact, several previous works have reported their potential activities, such as anticonvulsant, anti-HIV, anti-inflammatory and anticancer activities [ 35 , 36 , 37 , 38 , 39 , 40 ].…”
Section: Introductionmentioning
confidence: 99%
“…There is a vast number of thiazoles that exhibit a wide range of pharmacological activities, including antibacterial [ 29 ], anticancer [ 30 ], antifungal [ 31 ], anti-inflammatory [ 32 ], antioxidant [ 33 ] and anti-tubercular activities [ 34 ]. Therefore, we believe that the merging of pyrazole and thiazole moieties will result in a class of pharmacophores that exhibit promising biological activities; in fact, several previous works have reported their potential activities, such as anticonvulsant, anti-HIV, anti-inflammatory and anticancer activities [ 35 , 36 , 37 , 38 , 39 , 40 ].…”
Section: Introductionmentioning
confidence: 99%
“…In essence, the aim of molecular hybridization is to produce a single chemical entity through combination of two or more distinct pharmacophore subunits present in the structures of two or more known bioactive derivatives. For example, pyrazole and thiazole derivatives can be cited as examples of the successful application of this strategy [2][3][4][5][6]. 5) is also based on 3-(pyrazol-3ylamino)-isoquinolin-1(2H)-ones [12].…”
Section: Introductionmentioning
confidence: 99%
“…The strong activity in suppressing proliferation and growth of glioblastoma cells [13], colorectal (SW620, HT29, GI50 = 23.8÷24.13 M) [14] and CNS (SF-295, GI = 55%) [15] human cancer cell lines was found for condensed derivatives having a 3-aminoisoquinolinone moiety (6). The unsaturated 5H-benzo [4,5]imidazo [1,2b]isoquinolin-1-one (7) exhibited significant Cdc25B inhibition (IC50 = 5.3 M) [11]. In this context, the consolidation of the 3aminoisoquinolinone template and novel carbo/heteroaromatic rings as novel pharmacophores seems to be promising for obtaining highly effective anticancer drugs.…”
Section: Introductionmentioning
confidence: 99%
“…The literature survey on the synthesized five-membered heterocycles with two heteroatoms from 1,3-oxazoles class highlighted that they are also endowed with a wide range of potent pharmacological activities [ 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 ], such as antifungal, antibacterial (e.g., sulfaguanole with trade name: Enterocura, a sulfanilamide drug used for patients with acute diarrhea), anticancer (e.g., mubritinib), analgesic, antipyretic, anti-inflammatory (e.g., oxaprozin, a COX-2 inhibitor currently in the market, romazarit, the Roche candidate, which was withdrawn due to its toxicity profile), and anti-diabetic (e.g., darglitazone, an antihyperglycemic agent belonging to the glitazone class) effects. The structures of the representative bioactive synthetic compounds sharing the 1,3-oxazole scaffold are presented in Figure 2 .…”
Section: Introductionmentioning
confidence: 99%